Literature DB >> 24941930

Discriminating infectious meningitis versus neuropsychiatric involvement in patients with systemic lupus erythematosus: a single-center experience.

Jinyun Chen1, Xuebing Feng, Hong Wang, Bingzhu Hua, Congzhu Ding, Bujun Liu, Lingyun Sun.   

Abstract

The objective of this study is to identify the clinical differences between infectious meningitis and neuropsychiatric systemic lupus erythematosus (NPSLE) in patients with SLE. Clinical manifestations, laboratory test results, and prognoses of 14 SLE patients complicated with various infectious meningitis, hospitalized in the Affiliated Drum Tower Hospital of Nanjing University Medical School in the past 7 years, were reviewed and compared with those of 34 concomitantly treated NPSLE patients. Our study shows that mortality rate was much higher in SLE patients with infectious meningitis than in NPSLE patients. Compared to NPSLE, those with infectious meningitis had lower SLE Disease Activity Index (SLEDAI), but higher doses of corticosteroids 1 month before the occurrence of CNS symptoms. Headache, high fever, and vomiting were more common in patients with infectious meningitis, accompanied with the elevation of C-reactive protein level. Cerebrospinal fluid (CSF) examination showed increased levels of leukocytes and proteins but decreased glucose level in patients with infectious meningitis. We conclude that for SLE patients exhibiting CNS symptoms, high fever, high intake of corticosteroids, and abnormal CSF are important clues for the coexistence of infectious meningitis, especially tuberculous meningitis.

Entities:  

Mesh:

Year:  2014        PMID: 24941930     DOI: 10.1007/s10067-014-2726-8

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  23 in total

Review 1.  Infectious CNS disease as a differential diagnosis in systemic rheumatic diseases: three case reports and a review of the literature.

Authors:  K Warnatz; H H Peter; M Schumacher; L Wiese; A Prasse; F Petschner; P Vaith; B Volk; S M Weiner
Journal:  Ann Rheum Dis       Date:  2003-01       Impact factor: 19.103

2.  Meningitis in Korean patients with systemic lupus erythematosus: analysis of demographics, clinical features and outcomes; experience from affiliated hospitals of the Catholic University of Korea.

Authors:  J-M Kim; K-J Kim; H-S Yoon; S-K Kwok; J-H Ju; K-S Park; C-S Cho; H-Y Kim; S-H Park
Journal:  Lupus       Date:  2011-01-31       Impact factor: 2.911

3.  Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

Authors:  C Bombardier; D D Gladman; M B Urowitz; D Caron; C H Chang
Journal:  Arthritis Rheum       Date:  1992-06

4.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

5.  The prevalence and clinical characteristics of systemic lupus erythematosus with infectious brain lesions in China.

Authors:  Y Xu; D Xu; T Zhang; X-M Leng; F-C Zhang; X-F Zeng
Journal:  Scand J Rheumatol       Date:  2012-07-24       Impact factor: 3.641

6.  Tuberculosis in systemic lupus erythematosus in an endemic area and the role of isoniazid prophylaxis during corticosteroid therapy.

Authors:  Mo Yin Mok; Yi Lo; Tak Mao Chan; Woon Sing Wong; Chak Sing Lau
Journal:  J Rheumatol       Date:  2005-04       Impact factor: 4.666

7.  Central nervous system infections in patients with systemic lupus erythematosus.

Authors:  Jeng-Juh Hung; Liang-Shiou Ou; Wen-I Lee; Jing-Long Huang
Journal:  J Rheumatol       Date:  2005-01       Impact factor: 4.666

8.  High-sensitivity C-reactive protein and erythrocyte sedimentation rate in systemic lupus erythematosus.

Authors:  N Firooz; D A Albert; D J Wallace; M Ishimori; D Berel; M H Weisman
Journal:  Lupus       Date:  2011-03-24       Impact factor: 2.911

Review 9.  Tuberculosis in patients with systemic rheumatic or pulmonary diseases treated with glucocorticosteroids and the preventive role of isoniazid: a review of the available evidence.

Authors:  Matthew E Falagas; Paraskevi T Voidonikola; Anna G Angelousi
Journal:  Int J Antimicrob Agents       Date:  2007-10-29       Impact factor: 5.283

10.  Causes and predictors of mortality in hospitalized lupus patient in Sarawak General Hospital, Malaysia.

Authors:  C L Teh; G R Ling
Journal:  Lupus       Date:  2012-10-30       Impact factor: 2.911

View more
  1 in total

Review 1.  Central nervous system infections in patients with systemic lupus erythematosus: a systematic review and meta-analysis.

Authors:  Kasra Molooghi; Fereshte Sheybani; Hamidreza Naderi; Zahra Mirfeizi; Negar Morovatdar; Ashkan Baradaran
Journal:  Lupus Sci Med       Date:  2022-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.